No 1 Date of announcement 2026/02/24 Time of announcement 18:54:38 Subject A Phase 1 clinical trial of SNS851 has been approved by Australia HREC and acknowledged by Australia TGA. To which item it meets paragraph 10 Date of events 2026/02/24 Statement Date of occurrence of the event: 2026/02/24 New drug name or code: SNS851...Read More